Sökning: "intratumoral heterogeneity"
Visar resultat 1 - 5 av 13 avhandlingar innehållade orden intratumoral heterogeneity.
1. Integrative modeling of intratumoral heterogeneity, plasticity and regulation in nervous system cancers
Sammanfattning : The adult brain tumor glioblastoma (GBM) is characterized by short survival and a lack of efficient treatments. Median survival is 15 months from time of diagnosis and the 5-year survival rate is only 7 %. LÄS MER
2. Glioblastoma heterogeneity and plasticity : Investigating the roles of BMP4 and SOX2
Sammanfattning : The malignant primary brain tumor glioblastoma has a dismal prognosis and is distinguished by its heterogeneous character. Current treatment with surgical resection, radiotherapy and adjuvant chemotherapy with the alkylating agent temozolomide does not provide a cure, but simply prolongs survival by a few months. LÄS MER
3. Intratumoral heterogeneity in glioblastoma: subtype transition and cell-to-cell communication
Sammanfattning : Glioblastoma is a most aggressive brain tumor with a median overall survival of less than two years. The current treatment is surgery, chemotherapy, and radiotherapy. However, glioblastoma is difficult to treat and recurs some time after treatment. LÄS MER
4. Immunological aspects of intratumoral chemotherapy and immunotherapy in malignant brain tumors
Sammanfattning : Advances in surgery, chemo- and radiotherapy have only modestly improved survival rates of malignant brain tumor patients during the last decades. Emerging evidence suggests that an efficient treatment of malignant brain tumors will likely require the management of multiple aspects of tumor pathobiology in order to manipulate features as tumor heterogeneity and tumor immunosuppression. LÄS MER
5. Exploring inter- and intra-heterogeneity in childhood neuroblastoma and pheochromocytoma
Sammanfattning : Neuroblastoma is the most common extra-cranial solid tumor of the sympathoadrenal cell lineage, which is a unique pediatric malignancy with remarkable inter- and intra-tumoral heterogeneity. In infants, neuroblastoma can regress spontaneously without treatment, while in older patients, neuroblastoma can develop with lethal progression with less than a 50% survival rate. LÄS MER